EODData

MEMBERSHIP REGISTER LOG IN

FRA, 3G6: GNI Group Ltd

17 Aug 2026
LAST:

14.20

CHANGE:
 1.40		OPEN:
14.20		HIGH:
14.20		ASK:
0.00		VOLUME:
0
CHG(%):
8.97		PREV:
15.60		LOW:
14.20		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
17 Aug 2614.2014.2014.2014.200
14 Aug 2615.6015.6015.6015.600
13 Aug 2615.3015.3015.3015.300
12 Aug 2615.4015.4015.4015.400
07 Aug 2614.7014.7014.7014.700
06 Aug 2614.6014.6014.6014.600
05 Aug 2614.0014.0014.0014.000
04 Aug 2613.6013.6013.6013.600
03 Aug 2613.4013.4013.4013.400
31 Jul 2613.1013.1013.1013.100

PROFILE

Name:GNI Group Ltd
About:GNI Group Ltd. engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally. The company offers Etuary for the treatment of idiopathic pulmonary fibrosis. It also developing Etuary, which is in Phase III clinical trial for the treatment of connective tissue associated interstitial lung disease; and in clinical trial pre-phase III clinical trial pilot study for the treatment of radiation pneumonitis, as well as for the treatment of diabetic nephropathy. In addition, the company involved in developing F351, which is in Phase III clinical trial for the treatment of liver fibrosis; and F573 that is in phase II for the treatment of acute on chronic liver failure, as well as Tamibarotene for the treatment of acute promyelocytic leukemia. GNI Group Ltd. was incorporated in 2001 and is headquartered in Tokyo, Japan.
Sector:Healthcare
Industry:Biotechnology
Address:Nihonbashi-Honcho YS Building, Tokyo, Japan, 103-0023
Website:https://www.gnipharma.com
ISIN:JP3386370005
LEI:5299005KSTCN0WVJMQ52

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:124.62 
PEG Ratio:-0.65 
Price to Sales:0.03 
Price to Book:2.83 
Profit Margin:-0.22 
Operating Margin:-0.50 
Return on Assets:-0.05 
Return on Equity:-0.22 
Revenue:146.49M 
Shares:55.56M 
Market Cap:788.89M 

TECHNICAL INDICATORS

MA5:15.045.9%
MA10:14.391.3%
MA20:13.673.9%
MA50:13.862.5%
MA100:14.925.0%
MA200:14.421.5%
STO9:36.36
STO14:62.16
RSI14:55.07
WPR14:-37.84
MTM14:0.80
ROC14:0.06 
ATR:0.49 
Week High:15.609.9%
Week Low:14.200.0%
Month High:15.609.9%
Month Low:11.901.5%
Year High:19.6038.0%
Year Low:11.9019.3%

RECENT SPLITS

Date Ratio
02 Sep 20193-1
27 Jun 20181-10